ASCENDIS PHARMA A/S - ADR (ASND) Stock Analyst Ratings
NASDAQ:ASND - Nasdaq - US04351P1012 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 88% to ASND. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 237.28. This target is 23.84% above the current price.
ASND was analyzed by 23 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about ASND.
In the previous month the buy percentage consensus was at a similar level.
ASND was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-08-08 | UBS | Maintains | Buy -> Buy |
| 2025-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-08 | Stifel | Maintains | Buy -> Buy |
| 2025-08-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-08-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-06-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-06-09 | B of A Securities | Maintains | Buy -> Buy |
| 2025-06-03 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-12 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-05 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2025-05-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-02 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-05-02 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-05-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-16 | RBC Capital | Initiate | Outperform |
| 2025-03-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-25 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-02-18 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-02-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-13 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-02-11 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-07 | UBS | Initiate | Buy |
| 2024-11-15 | TD Cowen | Maintains | Buy -> Buy |
| 2024-11-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-15 | Oppenheimer | Maintains | Outperform -> Outperform |